Aditxt, Inc. (ADTX) Financial Statements (2025 and earlier)

Company Profile

Business Address 737 N. FIFTH STREET, SUITE 200
RICHMOND, VA 23219
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments972,7697,87210,501
Cash and cash equivalent972,7697,87210,501
Receivables 528590 
Inventory, net of allowances, customer advances and progress billings746950495 
Inventory746950495 
Prepaid expense217497460148
Intangible current assets    321
Other undisclosed current assets5,853  64
Total current assets:6,9134,7449,41711,033
Noncurrent Assets
Operating lease, right-of-use asset2,200  1,256
Property, plant and equipment1,898   
Long-term investments and receivables 22,277   
Long-term investments 22,277   
Intangible assets, net (including goodwill)9107214321
Intangible assets, net (excluding goodwill)9107214321
Deposits noncurrent assets10635537972
Deferred costs  50  
Other noncurrent assets   290 
Other undisclosed noncurrent assets11,1745,4796,364414
Total noncurrent assets:37,6655,9927,2472,063
TOTAL ASSETS:44,57810,73516,66413,097
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:8,5551,9591,576242
Accounts payable    
Accrued liabilities    
Other undisclosed accounts payable and accrued liabilities8,5551,9591,576242
Debt15,653147  
Deferred rent credit159189186 
Other liabilities    7
Other undisclosed current liabilities1,5231,3501,846979
Total current liabilities:25,8903,6443,6071,227
Noncurrent Liabilities
Long-term debt and lease obligation:    858
Liabilities, other than long-term debt1,042   
Operating lease, liability1,042  858
Derivative instruments and hedges, liabilities    
Other undisclosed noncurrent liabilities 1,6001,8852,876(858)
Total noncurrent liabilities:2,6421,8852,876858
Total liabilities:28,5325,5296,4832,085
Temporary equity, including noncontrolling interest    
Equity
Equity, attributable to parent, including:16,0565,20610,18111,011
Preferred stock    
Common stock144513
Treasury stock, value(202)(202)(202)(202)
Additional paid in capital143,998100,44477,69132,079
Accumulated deficit(127,741)(95,040)(67,353)(20,879)
Other undisclosed equity, attributable to parent0   
Equity, attributable to noncontrolling interest(10)   
Total equity:16,0475,20610,18111,011
TOTAL LIABILITIES AND EQUITY:44,57810,73516,66413,097

Income Statement (P&L) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues645934105 
Insurance commissions and fees 507   
Net investment income    
Cost of revenue(757)(767)(78)(154)
Cost of product and service sold  (767)(78)(154)
Gross profit:(112)16727(154)
Operating expenses(25,951)(25,647)(41,962)(8,872)
Other undisclosed operating income    154
Operating loss:(26,062)(25,480)(41,935)(8,872)
Nonoperating income (expense)(6,328)57(4,436)(277)
Investment income, nonoperating 5731
Interest and debt expense52(753)(16)22
Loss from continuing operations before equity method investments, income taxes:(32,339)(26,176)(46,387)(9,127)
Other undisclosed income (loss) from continuing operations before income taxes(52)(1,474)16 
Loss from continuing operations before income taxes:(32,390)(27,650)(46,371)(9,127)
Income tax expense   (100) 
Loss from continuing operations:(32,390)(27,650)(46,471)(9,127)
Loss before gain (loss) on sale of properties:(35,575)(9,127)
Income from discontinued operations  13,50010,896 
Other undisclosed net loss  (13,500)(10,796)(206)
Net loss:(32,390)(27,650)(46,371)(9,333)
Net income attributable to noncontrolling interest10   
Other undisclosed net income (loss) attributable to parent   184
Net loss attributable to parent:(32,381)(27,650)(46,371)(9,149)
Preferred stock dividends and other adjustments (320)   
Other undisclosed net income available to common stockholders, basic  3824,093 
Net loss available to common stockholders, diluted:(32,701)(27,612)(22,278)(9,149)

Comprehensive Income ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(32,390)(27,650)(46,371)(9,333)
Comprehensive loss:(32,390)(27,650)(46,371)(9,333)
Comprehensive income, net of tax, attributable to noncontrolling interest10   
Comprehensive loss, net of tax, attributable to parent:(32,381)(27,650)(46,371)(9,333)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: